Cargando…
Biomarkers for immune thrombocytopenia
Immune thrombocytopenia is an autoimmune disease with abnormal biomarkers. Immune thrombocytopenia pathogenesis is a complicated process in which the patient’s immune system is activated by platelet autoantigens resulting in immune mediated platelet destruction or suppression of platelet production....
Autores principales: | Yu, Lingjia, Zhang, Chunmei, Zhang, Liping, Shi, Yongyu, Ji, Xuebin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504091/ https://www.ncbi.nlm.nih.gov/pubmed/26185681 http://dx.doi.org/10.1186/s40364-015-0045-0 |
Ejemplares similares
-
T cell immune abnormalities in immune thrombocytopenia
por: Ji, Xuebin, et al.
Publicado: (2014) -
Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia
por: Allegra, Alessandro, et al.
Publicado: (2023) -
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
por: Datta, Payel, et al.
Publicado: (2021) -
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019) -
Emerging Therapies in Immune Thrombocytopenia
por: Audia, Sylvain, et al.
Publicado: (2021)